← Open Payments lookup

DANESSA COLES: Open Payments

NPI 1013625086 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,666 in 60 payments from 24 companies in 2025. Trend: 2023 $4,339 · 2024 $2,715 · 2025 $1,666

Food & beverage: $1,337Education: $329
CompanyPaymentsAmount
Janssen Biotech, Inc.6$243
Alexion Pharmaceuticals, Inc.5$156
Novartis Pharmaceuticals Corporation6$140
Astellas Pharma US Inc4$122
Merck Sharp & Dohme LLC4$117
E.R. Squibb & Sons, L.L.C.5$104
SANOFI-AVENTIS U.S. LLC1$91
Myriad Genetic Laboratories, Inc.3$74
TAIHO ONCOLOGY, INC.3$73
GENZYME CORPORATION2$65

Products named: ULTOMIRIS, SARCLISA, KEYTRUDA, OPDIVO, TECVAYLI, ERLEADA, DARZALEX, MYRISK.

Industry payments across CA — which companies pay providers there.